ClinicalTrials.gg
Not yet recruitingNCT07775066AFP-SUHUpdated Sep 11, 2026

Pattern of AFP in Chhidren Admitted at Sohag University Hospital

An observational study in Acute Flaccid Paralysis, AFP and Gullian Barre Syndrome, sponsored by Mohamed Aboelhamd Ali. Not yet recruiting at 1 site in Egypt. Open to participants aged 1 Month to 16 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Mohamed Aboelhamd Ali · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
30
Ages
1 Month to 16 Years
Sex
All
01

Study summary

This study is observational study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children at Sohag University Hospital.

This study will include all children admitted to pediatric emergency and intensive care units with claim or suspicion to have acute falccid paralysis

Read the detailed description

This study is a single center, Observational Cross Sectional Hospital Based study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children aged from birth to 18 years old at Sohag University Hospital.

All included children with acute flaccid paralysis will be subjected to:

All routine investigation (complete blood count, C.R.P, blood gases, serum electrolytes, coagulation profile, liver and kidney function test) Imaging when indicated (Brain C.T, Brain and spine MRI, Nerve Conduction Study)

02

Conditions studied

  • Acute Flaccid Paralysis
  • AFP
  • Gullian Barre Syndrome
  • Transverse Myelitis

Browse trials for

Keywords

  • acute flaccid paralysis
  • afp
  • Transverse myelitis
  • Gullian Barre Syndrome
03

In context

Myelitis, Transverse

32 studies on the registry are indexed under Myelitis, Transverse; 10 are open to participants now.

This study's planned enrollment of 30 is below the median of 98 across 12 observational studies indexed under Myelitis, Transverse.

Browse Myelitis, Transverse studies →

Lead sponsor

This is the only study on the registry with Mohamed Aboelhamd Ali as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients aged from 1 month to 16 years old with acute muscle weakness admitted at Sohag University Hospital, Egypt

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients admitted to pediatric emergency and intensive care units with claim or suspected to have acute flaccid paralysis aged from 1 month Up to 16 years old

Exclusion criteria

Exclusion Criteria:

  • Children with flaccid paralysis due to causes other than neurogenic causes. No clear history or clinical picture of definite neurological cause. incomplete clinical data.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • AFP Patients

    Cjildren from birth to 18 years old with acute muscle weakness who are followed at sohag university hospital

    Other: Observitional follow-up

Interventions

  • OtherObservitional follow-up

    No expiremental intervention. Data will be collected from routine cinical care, medical records and folow up visits according to standard hospital protocols

06

What researchers measure

Primary outcomes

  1. Full recovery

    Full restoration of muscle strength and function.

    Time frame: 1 Year

Secondary outcomes

  1. Partial Recovery with Residual Weakness

    Persistent muscle weakness despite improvement

    Time frame: 1 Year

  2. Permanent Paralysis

    Irreversible loss of motor function due to destruction of motor neurons or severe nerve injury

    Time frame: 1 Year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual Participants data will not be shared due to patient privacy and data protection policies at Sohag University Hospital

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2026
First posted
Aug 20, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Sep 1, 2027
CompletionEst.
Sep 1, 2027
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07775066
Lead sponsor
Mohamed Aboelhamd Ali
Responsible party
Mohamed Aboelhamd Ali (Pediatric Resident, Al-Maragha Hospital, Sohag University) — Sponsor-investigator
First posted
Aug 20, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Mohamed Aboelhamd Ali
Contact
noway00557@gmail.com
01069741666

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion